Fondation de l'Hopital Maisonneuve-Rosemont
Montreal, QC H1T 4B3
Executive Director: Lucie Drapeau
Board Chair: Jean Laurin
Charitable Reg. #: 11930 4855 RR0001
Grade: BThe grade is based on the charity's public reporting of the work it does and the results it achieves.
Need for Funding
Full-time staff #17
Avg. Compensation $69,511
Top 10 Staff Salary Range
|$300k - $350k||0|
|$250k - $300k||0|
|$200k - $250k||0|
|$160k - $200k||1|
|$120k - $160k||0|
|$80k - $120k||3|
|$40k - $80k||5|
About Fondation de l'Hopital Maisonneuve-Rosemont:
Founded in 1978, Fondation de l’Hopital Maisonneuve-Rosemont (FHMR) raises funds for patient care, research and equipment at Hopital Maisonneuve-Rosemont. The hospital specializes in the fields of ophthalmology (study of eye diseases), immunology-oncology (cancer treatment) and nephrology (study of kidney diseases). It serves 668,000 people in Montreal. FHMR reports that 36% of the population suffers from at least one chronic illness and 16.7% of east-end Montreal’s population is over the age of 65.
In F2015, Fondation de l’Hopital Maisonneuve-Rosemont allocated $6.2m to the hospital. It spent $2.9m on purchasing equipment, $3m on research grants and $0.3m on teaching and training sessions. New equipment includes a $63,192 new neonatal unit that serves 550 premature babies each year and 4 hemodialysis machines for $90,000 each. FHMR also spent $50,000 on expanding the pediatrics unit. Hopital Maisonneuve-Rosemont contains the largest dialysis centre in Quebec, treating 76,500 patients each year. The foundation gives $50,000 to emerging researchers annually. In F2015, it gave a 5-year, $550,000 grant to Dr. Louis-Philippe Laurin to continue research on nephrology. The foundation further granted $220,000 to diabetes research and $13,000 to ALS research.
In F2015, Hopital Maisonneuve-Rosemont was selected by the medical technology firm, Second Sight to become the first centre in Quebec to use synthetic eye implants. The bionic eye, or Argus II Retinal Prosthesis, costs $250,000 and offers a solution to Retinitis Pigmentosa, a leading cause of blindness affecting 1.2 million people worldwide and 13,000 in Canada.
Fondation de l’Hopital Maisonneuve-Rosemont is a Big-Cap charity with donations of $17.9m in F2015. Administrative costs are 12% of total revenues and fundraising costs are 18% of total donations. Total overhead costs come to 30%, falling within Ci’s reasonable range. FHMR has funding reserves of $58.2m that can cover program costs for 9.4 years. Excluding donor-endowed funds of $31.5m, funding reserves can cover program costs for 5.8 years.
This charity report is an update that is being reviewed by the charity. Changes and edits may be forthcoming.
Updated on July 25th, 2016 by Mirza Ali Shakir.
Financial RatiosFiscal year ending December
|Administrative costs as % of revenues||11.5%||9.3%||11.1%|
|Fundraising costs as % of donations||18.1%||17.5%||21.1%|
|Program cost coverage (%)||941.1%||536.0%||647.4%|
Summary Financial StatementsAll figures in $000s
|Cash flow from operations||8,515||6,668||7,996|